Nicholas Dodson
Podiatrist · Valdosta, GANPI 1144544842
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,450 of the $6,714 with a category attached, or 81.2%. Nextremity Solutions Inc. accounts for 74.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $3,681 and has fallen 92.8% since, to $264 in 2025.
Across 44 payments — averaging $152.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nextremity Solutions Inc.$5K
- Organogenesis Inc.$570
- Medartis Inc.$545
- Sanara Medtech Inc.$282
- Zimmer Biomet$109
- Paragon 28, Inc.$94
- plus $137 from 4 others
What the payments were for
- Consulting fees$5,45081%
- Food & beverage$1,26419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nextremity Solutions Inc. | 4 | $4,976 |
| Organogenesis Inc. | 22 | $570 |
| Medartis Inc. | 1 | $545 |
| Sanara Medtech Inc. | 5 | $282 |
| Zimmer Biomet | 3 | $109 |
| Paragon 28, Inc. | 1 | $94 |
| Integra Lifesciences Corporation | 5 | $83 |
| Convatec Inc. | 1 | $23 |
| Merck | 1 | $16 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$545
- VIA MATRIX$147
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
How this compares
$6,714 in reported general payments places this provider in the 80th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 77 | $2,120 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 113 | $1,525 |
| Diclofenac Sodium | 71 | $1,196 |
| Ciclopirox | 32 | $977 |
| Mupirocin | 92 | $722 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $649 |
| Gabapentin | 24 | $517 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $347 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $337 |
| Levofloxacin | 48 | $334 |
| Cephalexin | 56 | $319 |
| Methylprednisolone | 46 | $312 |
| Clindamycin Hcl | 28 | $266 |
| Ciprofloxacin Hcl | 40 | $249 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $167 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Valdosta
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.